NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.75

15 Apr
2024

-0.010

OPEN

$7.78

-0.13%

HIGH

$7.79

471,269

LOW

$7.70

TARGET
$8.068 4.1% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NOL . PSI . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 46.5 xxx
DPS (cps) xxx N/A 31.4 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 16.7 xxx
Dividend Yield xxx N/A 4.0% xxx
Div Pay Ratio(%) xxx N/A 67.4% xxx

Dividend yield today if purchased 3 years ago: 5.12%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.61

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 07/03 - ex-div 15c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx41.4
DPS All xxxxxxxxxxxxxxx28.0
Sales/Revenue xxxxxxxxxxxxxxx3,121.7 M
Book Value Per Share xxxxxxxxxxxxxxx200.3
Net Operating Cash Flow xxxxxxxxxxxxxxx246.7 M
Net Profit Margin xxxxxxxxxxxxxxx6.33 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx23.42 %
Return on Invested Capital xxxxxxxxxxxxxxx17.39 %
Return on Assets xxxxxxxxxxxxxxx9.56 %
Return on Equity xxxxxxxxxxxxxxx23.42 %
Return on Total Capital xxxxxxxxxxxxxxx26.08 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx125.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx9 M
Long Term Debt xxxxxxxxxxxxxxx283 M
Total Debt xxxxxxxxxxxxxxx292 M
Goodwill - Gross xxxxxxxxxxxxxxx365 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx243 M
Price To Book Value xxxxxxxxxxxxxxx4.22

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx52.3 M
Capex % of Sales xxxxxxxxxxxxxxx1.68 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx597 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,077 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

27/02/2024

1

Buy

$9.30

20.00%

First half results from nib Holdings were ahead of forecasts. UBS asserts the positive investment view that margins will remain higher for longer is intact. Market debate around margin quality and visibility on claims inflation may ensue nonetheless.

The  broker found policy numbers reasonable and probably signalling market share gains over the six months, although since the AGM in October sales momentum has clearly slowed. FY24 guidance has not been altered.

Buy rating maintained. Target is reduced to $9.30 from $9.50.

FORECAST
UBS forecasts a full year FY24 dividend of 34.00 cents and EPS of 50.00 cents.
UBS forecasts a full year FY25 dividend of 32.00 cents and EPS of 50.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

NHF STOCK CHART